N. Restifo

Immunology · 2002–2019

A researcher in the Science corpus: 37 papers; trusts 15 researchers and is trusted by 25 researchers here, as inferred from the citation graph.

Subfields

• Immunology — 341 citations into it; #133 of 2,160 by trust here, #41 by citations
• Oncology — 200 citations into it; #118 of 1,698 by trust here, #38 by citations
• Molecular Biology — 97 citations into it; #8,025 of 17,773 by trust here, #2,516 by citations
• Genetics — 41 citations into it; #5,692 of 6,854 by trust here, #354 by citations

Whom N. Restifo trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. S. Rosenberg
2. M. Dudley
3. L. Gattinoni
4. D. Porter
5. Jie Yang
6. R. Morgan
7. C. Klebanoff
8. B. Levine
9. S. Baylin

Who trusts N. Restifo overall

1. S. Rosenberg
2. W. Zou
3. Witold Lasek
4. S. Spranger
5. Michael S. Rooney
6. M. Dudley
7. Jiezhong Chen
8. M. Smyth
9. I. Siddiqui

Papers from N. Restifo's perspective

Ordered by how strongly the researchers N. Restifo trusts endorse each paper. Same corpus, a different order for every researcher.

1. Adoptive immunotherapy for cancer: building on success (Nature reviews. Immunology)
2. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
3. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
4. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer (New England Journal of Medicine)
5. Cancer regression and neurologic toxicity following anti-MAGE-A3 TCR gene therapy (Journal of immunotherapy)
6. Adoptive cell transfer: a clinical path to effective cancer immunotherapy (Nature Reviews. Cancer)
7. A human memory T-cell subset with stem cell-like properties (Nature Medicine)
8. Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens (Journal of Clinical Oncology)
9. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells (Proceedings of the National Academy of Sciences of the United States of America)
10. Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. (Proceedings of the National Academy of Sciences of the United States of America)

Their papers

• Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer (2010) — 628 citations
• Cancer immunotherapy: moving beyond current vaccines (2004) — 3,071 citations
• Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. (2005) — 987 citations
• Cancer regression and neurologic toxicity following anti-MAGE-A3 TCR gene therapy (2013) — 1,094 citations
• Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. (2011) — 1,605 citations
• Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells (2003) — 1,015 citations
• Defining ‘T cell exhaustion’ (2019) — 1,291 citations
• Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism (2018) — 636 citations
• Identification of essential genes for cancer immunotherapy (2017) — 770 citations
• Ionic immune suppression within the tumour microenvironment limits T cell effector function (2016) — 607 citations
• Adoptive cell transfer as personalized immunotherapy for human cancer (2015) — 2,295 citations
• A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T cell receptor: Long term follow up and correlates with response (2014) — 728 citations
• Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. (2013) — 897 citations
• Human memory T cells: generation, compartmentalization and homeostasis (2013) — 866 citations
• Adoptive immunotherapy for cancer: harnessing the T cell response (2012) — 1,673 citations
• A human memory T-cell subset with stem cell-like properties (2011) — 1,888 citations
• Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy (2011) — 1,972 citations
• T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis. (2011) — 813 citations
• Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts (2010) — 881 citations
• Th17 cells promote cytotoxic T cell activation in tumor immunity (2009) — 782 citations